Evidence map›Paper›PMID 37675898›Full record

ArticleThyroid : official journal of the American Thyroid Association2023

Combination

Viswanath Gunda, Chandrayee Ghosh, Jiangnan Hu, Lisa Zhang, Ya Qin Zhang, Min Shen, Electron Kebebew

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Dual targeting of BRAFJournal of experimental & clinical cancer research : CR · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Viswanath GundaDepartment of Surgery, Stanford University, Stanford, California, USA.
Chandrayee GhoshDepartment of Surgery, Stanford University, Stanford, California, USA.ORCID 0000-0002-2336-8487
Jiangnan HuDepartment of Surgery, Stanford University, Stanford, California, USA.
Lisa ZhangEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Ya Qin ZhangNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA.
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA.
Electron KebebewDepartment of Surgery, Stanford University, Stanford, California, USA.ORCID 0000-0001-5254-1456
Stanford University · USNational Institutes of Health · US

Funding

Therapeutic targets and novel anticancer agents for endocrine cancersZIABC011286 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NILUBOL, NARIS · 2010 to 2025
$16.6M
Intramural NIH HHS ZIA BC011286
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsAxitinibCell Line, TumorHumansImidazolesIndolesMitogen-Activated Protein Kinase KinasesMutationOximesProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSulfonamidesTyrosine Kinase InhibitorsAxitinibBRAF protein, humandabrafenibImidazolesIndolesMitogen-Activated Protein Kinase KinasesOximesPLX 4720Protein Kinase InhibitorsProto-Oncogene Proteins B-rafSulfonamidesTyrosine Kinase Inhibitorsanaplastic thyroid canceraurorakinase BaxitinibBRAF mutationcombination treatmenttargeted therapy

Identifiers

PMID37675898
PMCPMC10625471
OpenAlexW4386506011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.